药物涂层球囊在不成熟自体动静脉内瘘的应用及初步结果  

Application and preliminary results of drug-coated balloons in immature autogenous arteriovenous fistula

作　　者：阚远晴 潘智裕 李华青[2] 潘天岳[1] 符伟国[1] 岳嘉宁[1] Kan Yuanqing;Pan Zhiyu;Li Huaqing;Pan Tianyue;Fu Weiguo;Yue Jianing(Department of Vascular Surgery,Institute of Vascular Surgery,National Clinical Research Center for Interventional Medicine,Zhongshan Hospital,Fudan University,Shanghai 200032;Department of Emergency Trauma and Vascular Surgery,Minhang Hospital,Fudan University,Shanghai 201100)

机构地区：[1]复旦大学附属中山医院、血管外科复旦大学血管外科研究所、国家放射与治疗临床医学研究中心,上海200032 [2]复旦大学附属闵行医院急诊创伤血管外科,上海201100

出　　处：《中国血管外科杂志（电子版）》2023年第4期311-313,318,共4页Chinese Journal of Vascular Surgery(Electronic Version)

基　　金：上海市“科技创新行动计划”自然科学基金项目(21ZR1413300)。

摘　　要：目的探讨药物涂层球囊(drug-coated balloon,DCB)应用于球囊辅助促成熟(balloon-assisted maturation,BAM)技术治疗不成熟自体动静脉内瘘(arteriovenous fistula,AVF)的效果。方法回顾性分析2019年1月至2023年8月复旦大学附属中山医院18例使用DCB进行首次BAM治疗的AVF不成熟患者临床资料。结果BAM手术技术成功率为100%,临床成功率为94.4%。术后6个月、1年、2年初级通畅率分别为83.0%、73.7%、39.5%,次级通畅率分别为93.8%、93.8%、70.3%。结论DCB应用于BAM技术治疗不成熟AVF的技术成功率、临床成功率优异,短中期通畅率均满意。Objective To explore the effect of drug-coated balloon(DCB)applied to balloon-assisted maturation(BAM)technology in the treatment of immature autogenous arteriovenous fistula(AVF).Methods The clinical data of 18 patients with immature AVF who were treated with BAM using DCB in Zhongshan Hospital,Fudan University from January 2019 to August 2023 were analyzed retrospectively.Results The technical success rate of BAM technology was 100%,and the clinical success rate was 94.4%.The primary patency rates at 6 months,1 and 2 years after surgery were 83.0%,73.7%and 39.5%,respectively,and the secondary patency rates were 93.8%,93.8%,and 70.3%,respectively.Conclusion The technical success rate and clinical success rate of DCB applied to BAM technology in the treatment of immature AVF is excellent,and the short-and mid-term patency rate are satisfactory.

关 键 词：球囊 血液透析 动静脉内瘘 通畅率 

分 类 号：R692.5[医药卫生—泌尿科学]